Biofrontera (BFRI) Change in Accured Expenses (2020 - 2025)

Biofrontera's Change in Accured Expenses history runs 6 years deep, the most recent figure standing at -$1.7 million for Q4 2025.

• On a quarterly basis, Change in Accured Expenses fell 321.32% year-over-year to -$1.7 million in Q4 2025; TTM through Dec 2025 was $610000.0, a 365.22% increase from a year earlier, with the FY2025 full-year figure at $610000.0, up 365.22% from the prior year.
• Change in Accured Expenses fell to -$1.7 million in Q4 2025 per BFRI's latest filing, from $746000.0 in the prior quarter.
• Across five years, Change in Accured Expenses topped out at $3.1 million in Q2 2023 and bottomed at -$6.5 million in Q4 2023.
• The 5-year median for Change in Accured Expenses is -$313500.0 (2022), against an average of -$517550.0.
• Across the five-year window, Change in Accured Expenses jumped 638.12% in 2022 and tumbled 321.32% in 2025, its largest moves.
• Year by year, Change in Accured Expenses stood at -$1.1 million in 2021, then plunged by 213.69% to -$3.4 million in 2022, then slumped by 93.1% to -$6.5 million in 2023, then soared by 93.98% to -$394000.0 in 2024, then tumbled by 321.32% to -$1.7 million in 2025.
• Per Business Quant, the three latest BFRI Change in Accured Expenses figures stand at -$1.7 million (Q4 2025), $746000.0 (Q3 2025), and $1.2 million (Q2 2025).